The hospital financial turnaround firm made an unsolicited offer to buy Care New England. The offer included a $250 million purchase price and a promise to invest $300 million in capital improvements.
StoneBridge Healthcare said it presented a nonbinding letter of intent to Care New England because it has been struggling financially for several years. Last week, the health system recorded a $13 million net loss for its fiscal year 2020.
Care New England CEO James Fanale, MD, dismissed the bid as the health system works to negotiate a potential merger with Providence-based Lifespan and affiliation with Brown University, also in Providence. The organizations said they are working to complete a definitive agreement by January.
“It’s abundantly clear that the best direction for Rhode Island’s healthcare future is the creation of a robust academic health system with the merger of Care New England and Lifespan, and a deep affiliation with Brown University,” Mr. Fanale said, according to the Providence Journal. “We are united in our commitment that a merger must only serve to strengthen Rhode Island’s healthcare system. The merger conversations we’ve embarked on are the right ones, and they will continue expeditiously and exclusively.”
More articles on healthcare industry transactions:
5 hospital deals challenged by the federal government in 2020
FTC aims to block Hackensack Meridian’s acquisition of New Jersey hospital
HonorHealth, FastMed to manage 30 urgent care clinics
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
